KALA BIO, Inc. Reports Financial Obligation Triggering Event
Ticker: KALA · Form: 8-K · Filed: Oct 1, 2025 · CIK: 1479419
Sentiment: neutral
Topics: debt, financial-obligation
TL;DR
KALA BIO just filed an 8-K about a financial obligation trigger - could be big.
AI Summary
KALA BIO, Inc. filed an 8-K on October 1, 2025, reporting a triggering event that accelerates or increases a direct financial obligation or an obligation under an off-balance sheet arrangement as of September 29, 2025. The filing does not specify the exact nature of the obligation or the financial impact.
Why It Matters
This filing indicates a potential acceleration or increase in KALA BIO's financial obligations, which could impact its liquidity and financial standing.
Risk Assessment
Risk Level: medium — The filing signals a potential change in financial obligations, which warrants attention but lacks specific details to assess the immediate severity.
Key Players & Entities
- KALA BIO, Inc. (company) — Registrant
- September 29, 2025 (date) — Date of earliest event reported
- October 1, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- 001-38150 (commission_file_number) — SEC File Number
- 27-0604595 (ein) — IRS Employer Identification No.
- 1167 Massachusetts Avenue (address) — Principal Executive Offices
- Arlington (city) — Principal Executive Offices
- MA (state) — Principal Executive Offices
- 02476 (zip_code) — Principal Executive Offices
FAQ
What specific financial obligation is being accelerated or increased?
The filing does not specify the exact nature of the financial obligation or the details of the acceleration or increase.
What is the date of the earliest event reported?
The date of the earliest event reported is September 29, 2025.
When was this Form 8-K filed?
This Form 8-K was filed on October 1, 2025.
What is KALA BIO, Inc.'s principal executive office address?
KALA BIO, Inc.'s principal executive office is located at 1167 Massachusetts Avenue, Arlington, MA 02476.
What is the SEC file number for KALA BIO, Inc.?
The SEC file number for KALA BIO, Inc. is 001-38150.
Filing Stats: 623 words · 2 min read · ~2 pages · Grade level 12.8 · Accepted 2025-10-01 08:00:32
Key Financial Figures
- $0.001 — e on which registered Common Stock, $0.001 par value per share KALA The Nasdaq C
- $29.1 million — rated and declared payable by Oxford is $29.1 million plus any additional interest due upon f
Filing Documents
- tm2527691d1_8k.htm (8-K) — 23KB
- 0001104659-25-095342.txt ( ) — 182KB
- kala-20250929.xsd (EX-101.SCH) — 3KB
- kala-20250929_lab.xml (EX-101.LAB) — 33KB
- kala-20250929_pre.xml (EX-101.PRE) — 22KB
- tm2527691d1_8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. KALA BIO, INC. Date: October 1, 2025 By: /s/ Mary Reumuth Mary Reumuth Chief Financial Officer and Corporate Secretary